123 related articles for article (PubMed ID: 37307894)
1. The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.
Rigillo G; Belluti S; Campani V; Ragazzini G; Ronzio M; Miserocchi G; Bighi B; Cuoghi L; Mularoni V; Zappavigna V; Dolfini D; Mercatali L; Alessandrini A; Imbriano C
Cancer Lett; 2023 Jul; 567():216262. PubMed ID: 37307894
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.
Belluti S; Semeghini V; Rigillo G; Ronzio M; Benati D; Torricelli F; Reggiani Bonetti L; Carnevale G; Grisendi G; Ciarrocchi A; Dominici M; Recchia A; Dolfini D; Imbriano C
J Exp Clin Cancer Res; 2021 Nov; 40(1):362. PubMed ID: 34782004
[TBL] [Abstract][Full Text] [Related]
3. NF-YAl drives EMT in Claudin
Londero M; Gallo A; Cattaneo C; Ghilardi A; Ronzio M; Del Giacco L; Mantovani R; Dolfini D
Cell Death Dis; 2023 Jan; 14(1):65. PubMed ID: 36707502
[TBL] [Abstract][Full Text] [Related]
4. NF-YA Overexpression in Lung Cancer: LUSC.
Bezzecchi E; Ronzio M; Dolfini D; Mantovani R
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31744190
[TBL] [Abstract][Full Text] [Related]
5. The Switch from NF-YAl to NF-YAs Isoform Impairs Myotubes Formation.
Libetti D; Bernardini A; Sertic S; Messina G; Dolfini D; Mantovani R
Cells; 2020 Mar; 9(3):. PubMed ID: 32214056
[TBL] [Abstract][Full Text] [Related]
6. NF-YA splice variants have different roles on muscle differentiation.
Basile V; Baruffaldi F; Dolfini D; Belluti S; Benatti P; Ricci L; Artusi V; Tagliafico E; Mantovani R; Molinari S; Imbriano C
Biochim Biophys Acta; 2016 Apr; 1859(4):627-38. PubMed ID: 26921500
[TBL] [Abstract][Full Text] [Related]
7. NF-YA Overexpression in Lung Cancer: LUAD.
Bezzecchi E; Ronzio M; Semeghini V; Andrioletti V; Mantovani R; Dolfini D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32075093
[TBL] [Abstract][Full Text] [Related]
8. Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.
Cappabianca L; Farina AR; Di Marcotullio L; Infante P; De Simone D; Sebastiano M; Mackay AR
J Exp Clin Cancer Res; 2019 Dec; 38(1):482. PubMed ID: 31805994
[TBL] [Abstract][Full Text] [Related]
9. NF-Y subunits overexpression in gastric adenocarcinomas (STAD).
Gallo A; Ronzio M; Bezzecchi E; Mantovani R; Dolfini D
Sci Rep; 2021 Dec; 11(1):23764. PubMed ID: 34887475
[TBL] [Abstract][Full Text] [Related]
10. NF-Y Subunits Overexpression in HNSCC.
Bezzecchi E; Bernardini A; Ronzio M; Miccolo C; Chiocca S; Dolfini D; Mantovani R
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208636
[TBL] [Abstract][Full Text] [Related]
11. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and alternative splicing of NF-YA in breast cancer.
Dolfini D; Andrioletti V; Mantovani R
Sci Rep; 2019 Sep; 9(1):12955. PubMed ID: 31506469
[TBL] [Abstract][Full Text] [Related]
14. OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.
Xia L; Gao J; Ma K; Lin H; Chen Y; Luo Q; Lian J
Pathol Res Pract; 2021 Aug; 224():153493. PubMed ID: 34098198
[TBL] [Abstract][Full Text] [Related]
15. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
17. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
18. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic transformation-dependent expression of a transcription factor NF-Y subunit.
Gu Z; Kuntz-Simon G; Rommelaere J; Cornelis J
Mol Carcinog; 1999 Apr; 24(4):294-9. PubMed ID: 10326866
[TBL] [Abstract][Full Text] [Related]
20. Elastin is a key factor of tumor development in colorectal cancer.
Li J; Xu X; Jiang Y; Hansbro NG; Hansbro PM; Xu J; Liu G
BMC Cancer; 2020 Mar; 20(1):217. PubMed ID: 32171282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]